RYAN MOGADAM: Open Payments
NPI 1558964445 · CHICOPEE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 16 payments from 8 companies in 2025. Trend: 2023 $67 · 2024 $223 · 2025 $425
Food & beverage: $325Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $100 |
| Organon LLC | 3 | $80 |
| ABBVIE INC. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Galderma Laboratories, L.P. | 3 | $49 |
| Arcutis Biotherapeutics, Inc. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| LEO Pharma Inc. | 1 | $17 |
Products named: TREMFYA, VTAMA, COSENTYX, NEMLUVIO, Zoryve, SKYRIZI, RINVOQ, LIBTAYO.
Industry payments across MA — which companies pay providers there.
